Filing Details
- Accession Number:
- 0001808805-25-000049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-12 19:19:33
- Reporting Period:
- 2025-05-08
- Filing Date:
- 2025-05-12
- Accepted Time:
- 2025-05-12 19:19:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1808805 | Nautilus Biotechnology Inc. | NAUT | Laboratory Analytical Instruments (3826) | 981541723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1857948 | Parag Mallick | C/O Nautilus Biotechnology, Inc. 2701 Eastlake Avenue East Seattle WA 98102 | Chief Scientist | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-05-08 | 12,000 | $0.73 | 20,491,892 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-05-12 | 1,500 | $0.73 | 20,493,392 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Represents the weighted average share price of an aggregate total of 12,000 shares purchased in the price range of $0.7058 to $0.7520 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Represents the weighted average share price of an aggregate total of 1,500 shares purchased in the price range of $0.7229 to $0.7334 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.